Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy

Liver

Volumn 20, Issue 5, 2000, Pages 381-386

  Halfon, Philippe ^a,e   Halimi, Gilles ^a   Bourlière, Marc ^b   Ouzan, Denis ^c   Durant, Jacques ^d   Khiri, Hascene ^a   Mercier, Laurence ^a   Gerolami, Victoria ^a   Cartouzou, Guy ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL SAINT JOSEPH   (France)

^c INSTITUT ARNAULT TZANCK   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e Hospital Ambroise Pare   (France)

Author keywords

Hepatitis C virus; Interferon resistance; Interferon therapy; Polymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; AMINO ACID; COMPLEMENTARY DNA; DOUBLE STRANDED RNA; NUCLEOTIDE; PROTEIN KINASE; VIRUS RNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHRONIC HEPATITIS; CONTROLLED STUDY; DRUG RESPONSE; EUROPE; FRANCE; GENE MUTATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; NONHUMAN; PROGNOSIS; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS TYPING;

ALANINE TRANSAMINASE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DRUG RESISTANCE; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033819735     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020005381.x     Document Type: Article

References (36)

1. Clinical outcomes after transfusion-associated hepatitis C
2. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis: Effects of dose and duration
3. Therapy of chronic hepatitis C: Overview
4. Prediction of response to interferon treatment of chronic hepatitis C
5. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b
6. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
7. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
8. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
9. Analysis of genotypes and amino acid residues 2209-2248 of the NS5A region of hepatitis C in relation to the response to interferon beta therapy
10. Mutations in NS5 A region and interferon response in hepatitis C 1b virus infected patients
11. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alpha
12. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alpha therapy in French patients
13. Mutations in the nonstructural 5a region of hepatitis C virus and response of chronic hepatitis C to interferon alpha
14. The interferon sensitivity determining region: All hepatitis C virus isolates are not the same
15. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the non-structural 5A protein
16. The N-terminal region of hepatitis C virus encoded NS5A is important for NS4A dependent phosphorylation
17. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
18. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region
19. There are two major types of hepatitis C virus in Japan
20. Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays
21. Seaview and phylo-win: Two graphic tools for sequence alignment and molecular phylogeny
22. Structure and organization of the hepatitis C virus genome isolated from human carriers
23. Interferon resistance of hepatitis C virus genotype 1b: Relationship to nonstructural 5A gene quasispecies mutations
24. Influence of therapeutic regimens on rates of HCV quasispecies diversification
25. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: A potential mechanism of interferon resistance
26. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication
27. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
28. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
29. Mutations in NS5A region and response to interferon in HCV genotype 2 infection
30. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
31. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy
32. Factors predictive of response to interferon alpha therapy in hepatitis C virus infection
33. The double stranded RNA-activated protein kinase induced by interferon ds-RNA-PK
34. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: Implication for translational regulation
35. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase
36. Identification of the double stranded RNA-binding domain of the human interferon-inductible protein kinase